Enhanced envista®

To arm you with the latest available knowledge on glaucoma diagnosis, management, and interventions, we’ve worked with Glaucoma Australia and called on experts in the field to contribute a diverse array of articles for this issue.

Dr Nathan Kerr is a renowned Australian ophthalmologist specialising in minimally invasive glaucoma and cataract surgeries. His exper tise and pioneering work, par ticularly in the iTrack Advance and Minijec t procedures, have positioned him at the forefront of glaucoma treatment.

Glaucoma.org.au

Vision 2020 Australia has called for significant investment in First Nations and children’s eye health and vision research in its budget submission to the federal Government.

EssilorLuxottica is to expand its local presence with the acquisition EyeQ Optometrists, subject to the terms of the transaction being met.

Three gene variants have been identified that may be contributing to the susceptibility of people of African ancestry to develop glaucoma.

Positive top-line results have been announced from a confirmatory clinical study for AVT06, a biosimilar to Eylea (aflibercept) developed by the biotech Alvotech.

mivision has launched a digital publication to complement distribution of its well established monthly printed ophthalmic journal.

Scientists have discovered compelling for the cytoprotective and proregenerative effects of a neuropeptide in promoting corneal healing after eye injury.

International has rejected as “inaccurate” and “misleading”, an article by United States researchers about the safety of low-level redlight ( LLRL) treatment for myopia.

Adopting the ‘365 breathing technique’ helped reduce intraocular pressure (IOP) in primary openangle glaucoma patients, a new study has found. In this randomised, controlled, interventional trial, 40 subjects were asked to adopt the ‘365 breathing technique’ in addition to their pharmacological glaucoma treatment. A control group of 40 participants continued only with their pharmacological glaucoma treatment.

Paediatric and neuroophthalmology specialist Dr Jane C. Edmonds has taken over as the 128th President of the American Academy of Ophthalmology (AAO). Dr Edmond is the inaugural Chair of the Department of Ophthalmology, the University of Texas at Austin, Dell Medical School. Dr Edmond said her priorities include addressing physician and staff shortages and the “ever-growing legislative battles which challenge our pre-eminence by granting non-physicians an increasing scope of practice”.

(AI) systems for diagnosing diabetic eye disease (DED) have the potential to increase DED screening rates in underserved youth, while also saving costs for patients and caregivers, according to a study published in Nature Communications.

A new study has linked exposure to artificial outdoor light at night to an increased risk of aged-related macular degeneration (AMD).

Following positive topline results for AR-15512, a candidate treatment for the signs and symptoms of dry eye disease (DED), Alcon has announced it will submit a new drug application to the United States Food and Drug Administration in mid-2024.

The University of Western Australia has graduated its first cohort of students from the Doctor of Optometry program, which commenced in 2021.

Sydney ophthalmologist and founder of Myopia Australia, Dr Loren Rose, has been laying the foundations to establish an International Myopia Registry via Save Sight Registries.

Rayner, a United Kingdom-based medical device manufacturer, has acquired Swiss-based firm, This (Think in System) AG, the inventor, developer and manufacturer of Sophi phaco emulsification machines.

Researchers from the Indiana University School of Medicine hope to develop new glaucoma therapies by testing human neurons and a regenerative therapy to rescue dying visual neurons.

A single act of generosity towards a young Fijian bee and watermelon farmer with a passion for helping his community has had an amazing flow on effect, leading to the first overseas aid mission by Optical Dispensers Australia (ODA) in July.

Following a sell-out inaugural conference in 2023, senior orthoptists Mara Giribaldi and Dr Chris Hodge have announced they will host the second Art of Ocular Imaging conference in Sydney in June.

A new contact lens-based continuous glaucoma monitoring system has undergone a first-in-human pilot study, tested on six health volunteers during an experiment that induced deliberate changes in intraocular pressure (IOP).

Patients with lung cancer treated with epidermal growth factor receptor inhibitors (egfris) may have an increased risk of new-onset keratitis, a united states study has found.

O-Show24 is just around the corner and, with a sold-out tradeshow, this boutique eyewear event in Sydney promises to be an exciting opportunity to discover all the latest trends ahead of Silmo in Paris.

Super sunday, optometry nsw/act’s annual flagship cpd event, is back for the 12th time, this time at doltone house, darling island in pyrmont – nsw’s first six-star green star building.

A phase 3 trial for an ophthalmic solution for treating patients with night vision disturbances is expected to begin soon.

A vision awareness event at the Australian Parliament House has been described as an “undoubtedly great success” with 150 parliamentarians having their eyes examined, numerous referrals made, and conversations initiated about the need for accessible eye examinations and low vision support.

A new study has linked changes in the eye – specifically the retina – to depression, suggesting visual health may be intricately tied to mental health.

Gelflex Laboratories has opened its doors to second year optometry students from the University of Western Australia (UWA) in an act that Head of School, Professor Garry Fitzpatrick described as “incredibly generous” and “an amazing educational opportunity ”.

Welcome to mivision’s 2024 glaucoma issue.

Just over a year ago, a glaucoma specialist told Duncan Craib he was “five minutes from midnight”: unless urgent action was taken, he’d likely be blind in two to three months.

In 2023, economics consultancy Evaluate reviewed the costs of developing glaucoma and the potential savings that might be delivered from better compliance with glaucoma treatment . As part of this review, Evaluate looked at the impact Glaucoma Australia’s patient support program had on patients’ compliance with their treatment and found that a substantial increase in public expenditure in the patient support program would both increase compliance rates and be cost-effective.

Worldwide, the number of patients suffering from glaucoma has likely already exceeded the estimated 76 million for the year 2020, and this number is expected to increase to almost 112 million people by 2040 as our populations age.1 Drs Katharina Bell and Vicki Chrysostomou, and Professor Jonathan Crowston, argue that research needs to focus on earlier interventions that include diet, exercise, and neuroprotective pharmacology.

Glaucoma, a leading cause of blindness, is witnessing significant advancements in treatment. The evolution in minimally invasive glaucoma surgeries (MIGS) and laser therapies like selec tive laser trabeculoplast y (SLT) have reshaped patient care. This ar ticle delves into recent developments, aiming to keep eye health professionals at the forefront of glaucoma management.

miophthalmology products

Ocular surface disease (OSD) is a debilitating condition that causes chronic ocular discomfort and impaired vision. It occurs at a higher rate in patients receiving treatment for glaucoma and undermines one of the primary treatment objectives in glaucoma management – to maximise quality of life (QoL). Carly James and Dr Colin Clement discuss the major risk factors for developing ocular surface disease in patients with glaucoma and explain why minimally invasive glaucoma surgery may be an optimal approach to treatment.

It takes considerable skill and resources to differentiate those that require treatment for glaucoma from those who do not, and to avoid over-treating.

Increasingly, individuals are assuming a greater role in managing their health conditions. Patient-derived data has transformed the management of several chronic diseases, such as hypertension and diabetes, where patients measure their own blood pressure or blood sugars and share this information with their health care providers to guide medication dosage adjustments. Glaucoma, with its pressure-dependent treatment target, is in a similar category; however, until recently there has been no appropriate tool for patient-derived measurements. The iCare Home2 tonometer offers real promise as a first step into this area.

Glaucoma is a leading cause of irreversible blindness and affects over 200,000 Australians over the age of 50, with an increasing prevalence. 1 Intraocular pressure (IOP) is considered the most important modifiable risk factor in glaucoma, and this underpins the principles of glaucoma management in the clinical setting. However, glaucoma can still progress despite well-controlled IOP, suggesting that other non-pressure dependent mechanisms exist.

Faced with an increasing prevalence of glaucoma in Australia, the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) is exploring new models for collaborative care that will ease the burden on eye health practitioners while achieving optimum outcomes for patients.

Compliance is an important yet often overlooked consideration when managing patients with glaucoma. This article presents a case study on the consequence of potentially avoidable glaucomatous progression that can occur in the face of poor patient compliance.

Optometrists employing optical coherence tomography (OCT) as a routine clinical tool, have a higher chance of referring patients for specialist glaucoma management than those without OCT, writes Dr Ben Ashby.

Online visual field technology is an exciting development in the field of glaucoma, with the potential to redefine the future of disease diagnostics and care. Forging the way is Melbournebased company, Eyeonic, with its novel product that offers visual field testing via any computer, tablet, or laptop.

Rural and remote optometry has provided Lian Walker with a crash course on the importance of cooperative care for glaucoma patients.

Every few years technologies come along that are game changers. In some instances, we can still make do with traditional ways of doing things, but in other cases such instruments and technology become ‘must have’ items. Alan Saks reflects on the rapid pace of change and takes a peek into the future.

Themed ‘Sharpening Your Focus’, the much-anticipated Australian Vision Congress (AVC 2024) is just around the corner, from 6–7 June.

In today’s digital world, the first place people look when they need a product, service or a solution is, you guessed it: Google. In fact, it's such an integral part of our lives that the word ’Google’ itself has become a verb. So for optometrists, local search engine optimisation (SEO) is a vital business strategy, as Paul Sallaway explains.

Frames + spectacle & contact lenses

Frames for Professionals

Struktur is a French eyewear brand, based in Normandy and renowned for its distinctively colourful and geometrical frames. Under the ownership of Thierry Bonhomme and Jean-François Lufeaux since 2018, the brand is enjoying increasing global success.

mifashion News

Among a line-up of local and interstate speakers, optometry western australia’s western australian vision education conference (wave) will feature international speaker dr jennifer simonson, clinical director of the boulder valley vision therapy centre in colorado.

Www.aco.org.au/courses

Au.customerservice@safilo.com